+44-1647-403003
+44-1647-403003
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Background: Nivolumab and pembrolizumab are the first two US FDA-approved monoclonal antibodies targeting PD-1 for Hodgkin lymphoma (HL) and provide promising results in the relapsed/refractory setting (HL patients relapsing after autologous stem cell transplantation [ASCT], or with chemorefractory disease and/ or ineligible for ASCT). An interesti... Read More»
Cinzia Pellegrini, Beatrice Casadei, Claudia Cellini, Lisa Argnani, Michele Cavo and Pier Luigi Zinzani
Case Report: J Cancer Sci Ther/Vol.10.6 149(2018)
DOI: 10.4172/1948-5956.1000534
Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
